By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German protein reagents and sample prep technology firm Caprotec Bioanalytics said yesterday that it has closed on a €4 million ($5 million) Series B financing round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.